Kyverna Therapeutics(KYTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KYTX Kyverna Therapeutics

盘前交易 05-14 05:10:50 EDT

14.63

+0.63

+4.50%

最高15.30	最低14.15	成交量48.01万
今开14.68	昨收14.00	日振幅8.21%
总市值6.31亿	流通市值3.30亿	总股本4,312万
成交额700.51万	换手率2.13%	流通股本2,257万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"KYTX","market":"US","secType":"STK","nameCN":"Kyverna Therapeutics","latestPrice":14.63,"timestamp":1715630400000,"preClose":14,"halted":0,"volume":480075,"delay":0,"floatShares":22573378,"shares":43115244,"eps":-89.61406,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.63,"latestTime":"05-14 05:10:50 EDT","open":14.68,"high":15.3,"low":14.15,"amount":7005130.54065,"amplitude":0.082143,"askPrice":18.91,"askSize":100,"bidPrice":6.5,"bidSize":20,"shortable":3,"etf":0,"ttmEps":-89.61406,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1715693400000},"adr":0,"listingDate":1707368400000,"adjPreClose":14.63,"postHourTrading":{"tag":"盘后","latestPrice":16,"preClose":14.63,"latestTime":"19:46 EDT","volume":5126,"amount":76135.89,"timestamp":1715644007976},"volumeRatio":1.7006435213192308},"requestUrl":"/m/hq/s/KYTX","defaultTab":"news","newsList":[{"id":"2417265001","title":"BUZZ-Leerink 将 Kyverna 评为 \"跑赢大盘\"。","url":"https://stock-news.laohu8.com/highlight/detail?id=2417265001","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2417265001?lang=zh_cn&edition=full","pubTime":"2024-03-05 00:20","pubTimestamp":1709569208,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    3月4日 - ** 券商Leerink 给予Kyverna Therapeutics   \"跑赢大盘\"评级，目标价为48美元。** 与该股上次收盘价相比，目标价有近73%的上涨空间 ** Leerink认为，Kyverna的CAR-T细胞疗法的早期结果表明，该疗法能够触发 \"免疫重置\"，使CAR-T疗法成为治疗自身免疫性疾病的临床前沿疗法。** CAR-T疗法涉及提取一种白细胞或T细胞，重新设计它们来攻击癌症，然后将它们输回体内。** 截至收盘，该公司股价自上月首次公开募股以来下跌了约 9","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2416161907","title":"美国研究综述-CommScope 控股公司、荷兰兄弟公司、赫斯公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2416161907","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2416161907?lang=zh_cn&edition=full","pubTime":"2024-03-04 15:01","pubTimestamp":1709535675,"startTime":"0","endTime":"0","summary":"    路透社3月4日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价，其中包括 CommScope Holding Company、Dutch Bros 和 Hess Corp。要点 * CommScope Holding Company   ：摩根大通将其评级从中性下调至减持  * 荷兰兄弟  ：Piper Sandler 将其评级从中性上调至增持              * Hess Corp   ：Susquehanna 将目标价从 152 美元上调至 156 美元   * Pioneer Natural Resources Co   ：苏斯克汉纳将目标价从237美元上调至246美元              * United Therapeutics Corp   ：摩根大通将目标价从294美元下调至280美元  以下是路透社周一报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://kyvernatx.com","stockEarnings":[{"period":"1week","weight":0.048},{"period":"1month","weight":-0.3578},{"period":"3month","weight":-0.5076},{"period":"6month","weight":-0.335},{"period":"ytd","weight":-0.335}],"compareEarnings":[{"period":"1week","weight":0.0084},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.0543},{"period":"6month","weight":0.1584},{"period":"1year","weight":0.2656},{"period":"ytd","weight":0.0959}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kyverna Therapeutics, Inc.于2018年6月以BAIT Therapeutics, Inc.的名义在特拉华州注册成立，并于2019年10月更名为Kyverna Therapeutics, Inc.。该公司是一家以患者为中心的临床阶段生物制药公司，专注于为患有自身免疫性疾病的患者开发细胞疗法。他们的目标是通过以患者为中心的方法、广泛的平台、对治疗免疫疾病的见解以及从细胞疗法在其他医学领域的成功应用中获得的经验，为患有自身免疫性疾病的患者带来改善疾病的治疗益处。","exchange":"NASDAQ","name":"Kyverna Therapeutics","nameEN":"Kyverna Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kyverna Therapeutics(KYTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kyverna Therapeutics(KYTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kyverna Therapeutics,KYTX,Kyverna Therapeutics股票,Kyverna Therapeutics股票老虎,Kyverna Therapeutics股票老虎国际,Kyverna Therapeutics行情,Kyverna Therapeutics股票行情,Kyverna Therapeutics股价,Kyverna Therapeutics股市,Kyverna Therapeutics股票价格,Kyverna Therapeutics股票交易,Kyverna Therapeutics股票购买,Kyverna Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kyverna Therapeutics(KYTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kyverna Therapeutics(KYTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}